INTRODUCTION
Of the estimated 3.4 million children living with HIV globally, 90% live in sub-Saharan Africa [1] . Although the number of children born with HIV is declining because of scale-up of prevention of mother-to-child transmission (PMTCT) programmes, growing numbers of HIV-infected children are surviving to adolescence because of the widespread rollout of antiretroviral therapy (ART) [2] . In addition, approximately one-third of HIVinfected infants survive to adolescence in the absence of ART, and children infected a decade ago when PMTCT programmes and early infant diagnosis were not available, are now presenting to health services in large numbers for the first time in older childhood and adolescence [3] . Consequently, the burden of paediatric HIV is shifting toward adolescents [2] .
Although the incidence of acute pulmonary infections in HIV is declining because of the use of cotrimoxazole prophylaxis and ART [4] [5] [6] 7 && ], chronic lung disease (CLD) is emerging as an important, but incompletely understood, complication among older children and adolescents living with HIV [8] . In particular, adolescents with delayed diagnosis of perinatally acquired HIV have a disproportionately high burden of chronic respiratory disease [ ]. Taken together, these studies suggest that CLD may be more common among HIV-infected adolescents than previously appreciated ( Table 1) .
The term CLD comprises a spectrum of lung diseases whose prevalence varies between lowincome and middle-income countries (LMICs) and high-income countries. The pathogenesis is multifactorial, but HIV-related immune dysfunction is likely to be important.
Bronchiectasis
Bronchiectasis is a well-recognized and irreversible cause of CLD among HIV-infected children and adolescents [20] . The bronchial architecture is distorted with bronchial diameter enlargement relative to the adjacent pulmonary artery, which appears as a 'ring' or 'tramline' pattern on chest radiography [21
A study from the USA in the pre-ART era reported that 6% of 749 HIV-infected children without preexisting lung disease developed radiographically or histologically determined bronchiectasis during an average of 6 years of follow-up [23] . In contrast, in two recent studies conducted in Zimbabwe and Malawi among older children and adolescents with perinatally acquired HIV, one-half had chest radiographic features consistent with bronchiectasis [8,11 & ]. Two-thirds of children in the African studies were on ART for at least a median duration of 20 months and had median CD4 þ greater than 350 cells/ml. The lower prevalence of bronchiectasis in the USA study despite unavailability of ART was probably due to earlier engagement with healthcare services, prompt treatment of infections and greater attention to maintaining adequate nutrition.
Multiple 
Constrictive obliterative bronchiolitis
In 2012, Ferrand et al. [8] first reported a high prevalence of chronic respiratory symptoms among perinatally HIV-infected children diagnosed in
KEY POINTS
Chronic lung disease is increasingly recognized as a complication among older children and adolescents with perinatally acquired HIV.
The burden of chronic lung disease disproportionally affects those living in LMICs.
The most common causes of chronic lung disease appear to be large and small airways disease, which may be poorly responsive to antiretroviral therapy once established.
The prevalence and incidence of lymphocytic interstitial pneumoniitis appear to have decreased dramatically with the global scale-up of antiretroviral therapy. adolescence, nearly three-quarters of whom were taking ART. This was the first study to perform high-resolution computed tomography (HRCT) in this context. Among the 56 adolescents with chronic respiratory symptoms, the most common HRCT finding was a mosaic pattern of decreased attenuation in 55% (Fig. 1) . Decreased attenuation was associated with reduced FEV 1 and chronic
Together with hypoxia and irreversible airflow obstruction, these findings are consistent with constrictive obliterative bronchiolitis (cOB). This was the first study to demonstrate cOB as a major cause of CLD. To the best of our knowledge, there are no reports of HIV-associated cOB among adolescents in high-income settings, although the findings by Shearer et al. [19 & ] could partly be explained by small airways disease. Because of the cross-sectional nature of these data, however, it is not possible to determine whether findings reflect abnormalities persisting from insults during childhood or recent-onset disease [28 & ].
The pathogenesis and natural history of cOB among HIV-infected adolescents is not well understood. This rare, usually progressive, and fibrotic and inflammatory condition involves the small airways involved in gas exchange, namely the terminal and respiratory bronchioles, but spares the lung parenchyma [29] . These bronchiolar lesions are patchy and may be missed on transbronchial biopsy. Clinically, cOB presents with progressive dyspnea and cough over weeks to months, and hypoxia may be detected in severe cases. The predominant diagnostic features of cOB are poorly reversible airflow obstruction, a mosaic pattern of decreased attenuation on HRCT, and air trapping on pulmonary function testing and/or expiratory HRCT images ( Fig. 1) . Chest radiographs are often normal, or may demonstrate only hyperinflation, until cOB is advanced. It has been mainly described in lung and stem cell transplant patients with chronic rejection and graft-versus-host disease, and as a sequela of community-acquired respiratory viral infections (i.e., influenza, parainfluenza, adenovirus, and respiratory syncytial virus) and cytomegalovirus infection. It is very rarely reported among HIVuninfected children after community-acquired respiratory viral infections. The high incidence of viral infections among children and adolescents with HIV may play an important role in the development of cOB, particularly in those with delayed diagnosis and treatment of HIV [25 & ]. Additionally, decreased attenuation was strongly correlated with bronchiectasis and bronchial wall thickening and dilatation on HRCT [8] , suggesting a continuum of pathological processes that links small and large airways involvement. Although disease course and prognosis of cOB are not known among HIVinfected adolescents, in other populations, cOB responds poorly to therapy and is associated with a high-risk of mortality over months to years.
Lymphocytic interstitial pneumonitis
Globally, LIP was the most common cause of CLD among HIV-infected children during the pre-ART era [20, 30, 31] . It is generally responsive to ART, although severe LIP may require adjunct corticosteroid therapy. The overall incidence of LIP has declined dramatically with the scale-up of ART, and in recent studies, LIP appears to be uncommon among older children and adolescents with HIV. A review of chest radiographic findings in HIV-infected children and adolescents reported that pulmonary tuberculosis and LIP accounted for 70 and 15% of cases, respectively [32 & ]. Threequarters of included studies, however, were conducted during the pre-ART and early ART era or in ART-naïve individuals. In two recent studies of generally ART-experienced HIV-infected adolescents from Zimbabwe, HRCT was strongly suggestive of LIP in less then 3% [8,16 & ].
Asthma
Conflicting data suggest that asthma risk may be higher among HIV-infected compared with HIVuninfected children and adolescents, especially in high-income settings [33, 34] . Among 1201 HIVinfected adolescents living in the USA, of whom 87% were perinatally infected and 85% were taking ART, asthma was a common comorbid condition with an incidence of 1.2/100 person-years [35 && ]. In a study of Thai children with perinatally acquired HIV, early initiation of ART was associated with higher CD4 þ , and the prevalence of asthma (27%) exceeded that of uninfected Thai children (18%) [36 & ]. Asthma tended to be more common among individuals with preserved immune function, and may be linked to immune reconstitution [36 & ,37-39] . However, the prevalence may have been overestimated in these studies, as diagnosis was based on self-report, diagnostic codes or prescription of asthma-related medications. In a study that performed spirometry in 216 perinatally HIV-infected adolescents in the USA, only 30% of those with airflow obstruction had bronchodilator reversibility (overall, 9% of those with interpretable spirometry) [19 & ]. In Zimbabwe, 3-5% of older children and adolescents with perinatally acquired HIV reported a history of asthma [13
& ], similar to the prevalence estimated in the general African paediatric population [40] . Reversibility with bronchodilators . Although asthma prevalence may be underestimated in LMICs wherein few systematic surveys have been completed, it is plausible that incidence is low, but could increase with industrialization, as observed in South Africa.
Pulmonary hypertension
HIV-related pulmonary arterial hypertension is rare with an estimated prevalence of 0.5% among adults in high-income countries; however, small studies from sub-Saharan Africa suggest a prevalence of 5-13% [41,42 & ]. Pulmonary hypertension is rarely described in HIV-infected children and adolescents [43] . A study in Zimbabwe reported that 4% of perinatally HIV-infected adolescents had elevated estimated pulmonary artery systolic pressure (>30 mmHg) on echocardiography [44] . Overall, 30% had right ventricular dilatation, and 24% had concurrent impaired left ventricular function. In another study, 28% of HIV-infected children and adolescents had right ventricular dilatation, and two-thirds had concomitant left heart abnormalities [45 & ]. Pulmonary hypertension prevalence, however, remains uncertain as echocardiography may over-underestimate or underestimate prevalence [46] , and use of pulmonary angiography, the diagnostic gold standard, is limited in LMICs.
HIV-related pulmonary hypertension in adolescents may be multifactorial as a sequela of HIV itself or secondary to HIV-associated immune dysfunction and/or cardiopulmonary disease [42 & ,47] . (Fig. 2) .
RISK FACTORS FOR HIV-ASSOCIATED CHRONIC LUNG DISEASE AMONG ADOLESCENTS

Pulmonary infections
Pulmonary pathogens can trigger local inflammation, resulting in scarring and destruction of lung tissue [49] . Pulmonary infections, such as Pneumocystis jirovecii pneumonia (PCP), bacterial
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Chronic lung disease Tobacco smoking FIGURE 2. Aetio-pathogenesis of chronic lung disease in HIV-infected adolescents (þ: increases risk; À: decreases risk).
pneumonia, and tuberculosis are associated with permanent lung function abnormalities among HIV-infected adults [50, 51] . Recurrent and severe pulmonary infections early in life are also associated with impaired lung function, and these early impairments may track through later life [52 & ,53] . Increasing availability of ART and cotrimoxazole have resulted in a decline in the incidence of bacterial pneumonia, pulmonary tuberculosis, and PCP [54, 55] . In LMICs, pulmonary infections remain common despite decreases in incidence, and risk of pulmonary infections is particularly high among those with delayed diagnosis and treatment of HIV [26,56 & ].
HIV infection, systemic immune activation, and chronic inflammation
HIV infection is associated with systemic immune activation and chronic inflammation [57] [58] [59] . This is driven by translocation of microbial products, including lipopolysaccharide, into the systemic circulation through a gastrointestinal mucosa made 'leaky' as a result of HIV-mediated inflammation of gut lymphoid tissue [59] [60] [61] . The resultant immune dysregulation is associated with end-organ damage [58, [62] [63] [64] , and may be important mechanistically in CLD development. HIV itself is an independent risk factor for chronic obstructive pulmonary disease (COPD) among adults [6, 65, 66] . Preliminary data suggest that HIV is also independently associated with CLD in children and adolescents ]. Infancy and early childhood are critical periods for organ and immune system development. HIV-mediated immune dysregulation may place children at high risk of lung damage, particularly those with untreated HIV, and recurrent pulmonary infections may further accelerate lung function decline. These pathophysiological mechanisms may partly explain why adolescents in LMICs, whereas HIV diagnosis and ART initiation are often delayed [67 & ,68], have a higher prevalence of CLD. Although ART reduces markers of inflammation, residual systemic immune activation, and chronic inflammation persist [61, 69] . The impact of ART on the course of CLD remains unclear. An African study reported a lower prevalence of cough, breathlessness, and hypoxia, but no difference in lung function among HIV-infected adolescents who had received ART for a median of 5 years compared with an age-matched group of ART-naïve adoles- ]. Cigarette smoking is a recognized risk factor for COPD and lung function decline among adults. Levels of cigarette smoking are increasing among adolescents, particularly in LMICs [70] . Therefore, tobacco smoke exposure will likely become an increasingly important contributor to development of CLD.
Exposure to household air pollution during early life has been associated with mortality and pulmonary infections, which in turn may impair lung function [48,71 & ,72] . Strong evidence also supports the association between household air pollution and CLD, including COPD in adults and wheezing in children [48] . To date, no studies have demonstrated a link between household air pollution and CLD among HIV-infected adolescents, likely because of confounding by other exposures and difficulties in measuring exposures. In the absence of appropriate diagnostics, chronic respiratory symptoms are frequently empirically treated with repeated courses of antibiotics and antituberculosis therapy in high-HIV prevalence settings wherein tuberculosis is common [8,15 & ,17]. The pathogenesis of CLD is poorly understood, and there are no specific management guidelines. However, prevention of pulmonary infections by ensuring routine vaccinations, early ART initiation and continued cotrimoxazole use may mitigate the burden of CLD among HIV-infected adolescents [78] .
Malnutrition and stunted growth
FUTURE DIRECTIONS
Prospective studies to understand the natural history, pathology, and pathogenesis of CLD in HIV-infected adolescents are needed. Standardization of the definition of CLD and of data collection/measurement will allow for comparability across studies and merging of data to achieve greater power to detect associations. Additionally, locally derived references for defining abnormal lung function in children are needed in LMICs. The 2016 WHO HIV guidelines recommend treatment of all individuals regardless of age or immune status, which should facilitate earlier ART initiation. However, once established, CLD does not appear to be completely reversed by ART. Screening algorithms for CLD for children and adolescents need to be developed, and interventions such as long-term macrolide therapy, prophylactic antibiotics, pulmonary rehabilitation, and tobacco smoke avoidance/cessation programmes require evaluation.
CONCLUSION
Recent studies demonstrate a high burden of CLD and its manifestations among HIV-infected older children and adolescents, particularly in LMICs. CLD represents a spectrum of conditions with overlapping risk factors and pathogenic mechanisms. As greater numbers of HIV-infected children survive to adolescence, the prevalence of CLD in this age-group is likely to increase. Further research is urgently needed to develop optimal diagnostic and therapeutic strategies so as to avoid compromising the substantial gains in mortality accomplished with ART among HIV-infected children. Respiratory symptoms, spirometry and HRCT were assessed in 39 older children and adolescents who received ART for at least 6 months. Findings consistent with obliterative/constrictive bronchiolitis and bronchiectasis were common on HRCT and were associated with cough and reduced FEV 1 ; however, an association between HRCT abnormalities and hypoxia or low-CD4 þ was not detected. 
